Chemoinformaics analysis of (1S)-1-METHYL-1,2,3,4-TETRAHYDROISOQUINOLINE-6,7-DIOL
| Molecular Weight | 179.219 | nRot | 0 |
| Heavy Atom Molecular Weight | 166.115 | nRig | 11 |
| Exact Molecular Weight | 179.095 | nRing | 2 |
| Solubility: LogS | -1.545 | nHRing | 1 |
| Solubility: LogP | 0.306 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 28.0723 |
| nHD | 3 | BPOL | 13.6117 |
| QED | 0.526 |
| Synth | 3.075 |
| Natural Product Likeliness | 1.747 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.061 |
| HIA | 0.008 |
| CACO-2 | -4.838 |
| MDCK | 0.00000744 |
| BBB | 0.036 |
| PPB | 0.23431 |
| VDSS | 1.977 |
| FU | 0.74294 |
| CYP1A2-inh | 0.042 |
| CYP1A2-sub | 0.411 |
| CYP2c19-inh | 0.031 |
| CYP2c19-sub | 0.1 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.14 |
| CYP2d6-inh | 0.098 |
| CYP2d6-sub | 0.867 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.238 |
| CL | 15.613 |
| T12 | 0.843 |
| hERG | 0.058 |
| Ames | 0.709 |
| ROA | 0.31 |
| SkinSen | 0.916 |
| Carcinogencity | 0.079 |
| EI | 0.028 |
| Respiratory | 0.47 |
| NR-Aromatase | 0.01 |
| Antiviral | No |
| Prediction | 0.874997 |